Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Short-Term Debt: R$425 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:PFRM3 Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
75 GF Score
Price R$6.25
GF Value R$8.10
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Profarma Distribuidora De Produtos Farmaceuticos Short-Term Debt?

Profarma Distribuidora De Produtos Farmaceuticos BSP:PFRM3 +0.81% 75 Short-Term Debt is R$425 Mil as of Mar. 2026. GuruFocus rates BSP:PFRM3 with a GF Score™ of 75/100 and a GF Value™ of R$8.10 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Profarma Distribuidora De Produtos Farmaceuticos's Short-Term Debt for the quarter that ended in Mar. 2026 was R$425 Mil.

Profarma Distribuidora De Produtos Farmaceuticos's quarterly Short-Term Debt declined from Sep. 2025 (R$415 Mil) to Dec. 2025 (R$311 Mil) but then increased from Dec. 2025 (R$311 Mil) to Mar. 2026 (R$425 Mil).

Profarma Distribuidora De Produtos Farmaceuticos's annual Short-Term Debt increased from Dec. 2023 (R$206 Mil) to Dec. 2024 (R$249 Mil) and increased from Dec. 2024 (R$249 Mil) to Dec. 2025 (R$311 Mil).

Profarma Distribuidora De Produtos Farmaceuticos Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Profarma Distribuidora De Produtos Farmaceuticos Short-Term Debt Related Terms

Profarma Distribuidora De Produtos Farmaceuticos Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Profarma Distribuidora De Produtos Farmaceuticos's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profarma Distribuidora De Produtos Farmaceuticos Short-Term Debt Chart

Profarma Distribuidora De Produtos Farmaceuticos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 117.65 131.02 206.28 248.54 311.14

Profarma Distribuidora De Produtos Farmaceuticos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 504.78 719.78 414.84 311.14 424.71
BSP:PFRM3
75GF Score
Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of R$425 Mil mean?
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a Short-Term Debt of R$425 Mil as of Mar. 2026.
Is Profarma Distribuidora De Produtos Farmaceuticos' Short-Term Debt too high?
Profarma Distribuidora De Produtos Farmaceuticos' current Short-Term Debt is R$425 Mil. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' Short-Term Debt compare to MCK and COR?
Profarma Distribuidora De Produtos Farmaceuticos' Short-Term Debt of R$425 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Profarma Distribuidora De Produtos Farmaceuticos's current Short-Term Debt is R$425 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.10, compared to a current price of R$6.25 — trading 22.8% below its estimated fair value. The current Short-Term Debt is R$425 Mil. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current Short-Term Debt is R$425 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?

Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued. The current stock price of R$6.25 is trading 22.8% below its estimated GF Value™ of R$8.10. GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.

Key valuation signals for BSP:PFRM3:

  • Short-Term Debt: R$425 Mil
  • GF Value™: R$8.10 vs. price of R$6.25 (22.8% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Profarma Distribuidora De Produtos Farmaceuticos Business Description

Address Avenida Ayrton Senna, 2.150, Bloco P, 3rd floor andar, Barra da Tijuca, RJ, BRA, 22775-900
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score

Get the complete analysis for BSP:PFRM3

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.25
Price
R$8.10
GF Value